Zhang Lele - Net Worth and Insider Trading

Zhang Lele Net Worth

The estimated net worth of Zhang Lele is at least $178 Million dollars as of 2024-12-28. Zhang Lele is the of Cutia Therapeutics and owns about 27,562,475 shares of Cutia Therapeutics (HKSE:02487) stock worth over $178 Million. Details can be seen in Zhang Lele's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Zhang Lele has not made any transactions after 2024-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Zhang Lele

To

Zhang Lele Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Zhang Lele owns 1 companies in total, including Cutia Therapeutics (HKSE:02487) .

Click here to see the complete history of Zhang Lele’s form 4 insider trades.

Insider Ownership Summary of Zhang Lele

Ticker Comapny Transaction Date Type of Owner
HKSE:02487 Cutia Therapeutics 2024-11-15 2101 Beneficial owner

Zhang Lele Latest Holdings Summary

Zhang Lele currently owns a total of 1 stock. Zhang Lele owns 27,562,475 shares of Cutia Therapeutics (HKSE:02487) as of November 14, 2024, with a value of $178 Million.

Latest Holdings of Zhang Lele

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02487 Cutia Therapeutics 2024-11-14 27,562,475 6.47 178,329,213

Holding Weightings of Zhang Lele


Zhang Lele Form 4 Trading Tracker

According to the SEC Form 4 filings, Zhang Lele has made a total of 2 transactions in Cutia Therapeutics (HKSE:02487) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Cutia Therapeutics is the sale of 0 shares on November 14, 2024, which brought Zhang Lele around $0.

Insider Trading History of Zhang Lele

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Zhang Lele Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Zhang Lele Ownership Network

Ownership Network List of Zhang Lele

No Data

Ownership Network Relation of Zhang Lele

Insider Network Chart

Zhang Lele Owned Company Details

What does Cutia Therapeutics do?

Who are the key executives at Cutia Therapeutics?

Zhang Lele is the 2101 Beneficial owner of Cutia Therapeutics. Other key executives at Cutia Therapeutics include 2201 Interest of corporation controlled by you Zhang Qiping , 2201 Interest of corporation controlled by you su zhou tong yu tou zi guan li he huo qi ye you xian he huo , and 2101 Beneficial owner su zhou tong he yu cheng tou zi he huo qi ye you xian he huo .

Cutia Therapeutics (HKSE:02487) Insider Trades Summary

Over the past 18 months, Zhang Lele made no insider transaction in Cutia Therapeutics (HKSE:02487). Other recent insider transactions involving Cutia Therapeutics (HKSE:02487) include a net sale of 3,165,600 shares made by Pandanus Associates Inc. , a net sale of 3,165,600 shares made by FIL Limited , and a net sale of 3,165,600 shares made by Pandanus Partners L.P. .

In summary, during the past 3 months, insiders sold 0 shares of Cutia Therapeutics (HKSE:02487) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,397,200 shares of Cutia Therapeutics (HKSE:02487) were sold and 497,400 shares were bought by its insiders, resulting in a net sale of 9,899,800 shares.

Cutia Therapeutics (HKSE:02487)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cutia Therapeutics Insider Transactions

No Available Data

Zhang Lele Mailing Address

Above is the net worth, insider trading, and ownership report for Zhang Lele. Currently GuruFocus does not have mailing address information for Zhang Lele.

Discussions on Zhang Lele

No discussions yet.